SLITRK5 is a cellular protein whose normal function appears to suppress bone formation and could be a potential new target for the treatment ofosteoporosis, according to a collaborative study conducted by Weill Cornell Medicine and NewYork-Presbyterian researchers.
Cells manifesting the SLITRK5 protein are marked with magenta (left) and a bone-forming osteoblast marker in green (center). These markers were observed in the cancellous bone in the medulla space (top) or on the outer layer covering the bone (bottom). The overlap between these two markers (right) shows that SLITRK5 is found in bone-forming osteoblasts but not in other cell types, helping to make SLITRK5 a target for skeletal disease treatment. Credit: Dr. Matthew Greenblatt and Dr. Jun Sun
There Research was published in the scientific journal Nature Communications.
Read Also
- Paralympics On his main trip, Henry Manni raced harder than initially planned and advanced to the 800-meter final Sep 3, 2021
- Man remains life-threatening after being shot in the head in the Reñaca Alto sector of Viña del Mar Nov 6, 2022
- Jair Bolsonaro’s anger with Bolivia for selling Argentina the gas that was for Brazil: “It’s all orchestrated” May 25, 2022
- Spain: Oldest Old Basque Text Discovered in Navarre Nov 15, 2022
- Single child allowance 2021 Inps, how to request it: useful information Jul 1, 2021
- Is Star in the Star plagiarism? The Rai Supervision intervenes Sep 4, 2021
- Google One offers a free backup of your smartphone (iOS or Android) Jul 31, 2020